← Back to NVAX

Novavax, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 06/08/2026Mar 2026Filed 06/05/2026Sep 2025Filed 06/11/2025Jun 2025Filed 06/08/2026Mar 2025Filed 06/05/2026Sep 2024Filed 06/11/2025Jun 2024Filed 06/08/2025Mar 2024Filed 08/05/2025
$57$140$70$239$667$85$415$94
−$53−$9.5−$202$107$519−$121$162−$148
−$0.32−$0.06−$1.25$0.62$2.93−$0.76$0.99−$1.05
165163162177178160166140

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.